Schizophrenia: Abilify Maintena is indicated for treatment of schizophrenia in adult patients stabilized with oral aripiprazole. Efficacy has been established in both acute and maintenance phases of schizophrenia.
Bipolar I Disorder: Abilify Maintena is indicated for the maintenance monotherapy treatment of bipolar I disorder in adult patients.
See Pharmacology: Pharmacodynamics under Actions for further information on clinical trials.